Literature DB >> 2287048

Management and evaluation of non-supervised home exercise program in a convalescent phase of acute myocardial infarction.

K Ueshima1, M Saito, A Shimohara, S Uchimoto, M Kawaguchi, K Fukami, T Sumiyoshi, K Haze, K Hiramori.   

Abstract

Out of 636 patients with acute myocardial infarction (AMI) admitted to our institution, 183 patients enrolled in our non-supervised home exercise program immediately after their discharge from the hospital. The first 40 patients were randomized to control and training group, while the remaining 143 patients were included in the training group. Before and after the trial, all patients underwent cardiopulmonary exercise testing; submaximal graded treadmill exercise test with the application of expiratory gas analysis. In the training group, patients performed 2 km walk-jog exercise everyday for 1 month, keeping their heart rate (HR) at 90-100% of that in the anaerobic threshold. HR during exercise was monitored by patients themselves, using HR-meter. The anaerobic threshold significantly increased in the training group; while control group had no significant changes. VO2 and HR significantly increased at the same Borg's indices. Psychological improvement was also obtained in the training group compared to control group. It is concluded that non-supervised home exercise program is effective and easily applicable in the convalescent phase of AMI.

Entities:  

Mesh:

Year:  1990        PMID: 2287048     DOI: 10.1253/jcj.54.11_1437

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  2 in total

1.  Cardiac rehabilitation.

Authors:  J Dinnes; J Kleijnen; M Leitner; D Thompson
Journal:  Qual Health Care       Date:  1999-03

2.  Relationship between double product break point, lactate threshold, and ventilatory threshold in cardiac patients.

Authors:  Kazuto Omiya; Haruki Itoh; Naomi Harada; Tomoko Maeda; Akihiko Tajima; Keiko Oikawa; Akira Koike; Tadanori Aizawa; Long-Tai Fu; Naohiko Osada
Journal:  Eur J Appl Physiol       Date:  2003-10-18       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.